INSYS Files For Court-supervised Sale Process - Quick Facts

(RTTNews) - INSYS Therapeutics, Inc. (INSY) has filed under Chapter 11 of the U.S. Bankruptcy Code in the Delaware Bankruptcy Court to initiate the sale of all of the company's assets. INSYS plans to complete the process within 90 days in order to address the legacy legal liabilities.

"After conducting a thorough review of available strategic alternatives, we determined that a court-supervised sale process is the best course of action to maximize the value of our assets and address our legacy legal challenges in a fair and transparent manner," said Andrew Long, CEO of INSYS.